trustmebro.to/r/…

✓ checked

trust me, bro:

here is the receipt.

the claim

Cancer cells emit specific volatile organic compounds as chemical signatures

the verdict

SUPPORTED

the evidence backs this

Recorded sources

7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that cancer cells emit specific volatile organic compounds as chemical signatures?

Yes. Multiple clinical and in vitro studies demonstrate that cancer cells and tumors emit specific volatile organic compounds that serve as detectable chemical signatures for non-invasive diagnostics.

Verdict: SUPPORTED · 7 sources for, 0 against · Last checked 5 Aug 2026

The analysis

The claim states that cancer cells emit specific volatile organic compounds as chemical signatures. Papers [0], [1], [2], [3], [4], [5], and [8] all provide strong empirical or review evidence that cancer cells, tissues, and tumors produce distinct volatile organic compounds that can be detected in vitro or via breath analysis to identify various cancers. There are no refuting papers.

Evidence for · 7

Emerging Electronic Nose Design for Breath-Based Cancer Diagnostics: Advances in Machine Learning Approaches and Sensor Architecture Design.

2026

Reviews electronic nose technologies for detecting cancer-related volatile organic compounds in breath.

Get citation

FS, G., M, B., Q, W., J, Q., & A, T. (2026). Emerging Electronic Nose Design for Breath-Based Cancer Diagnostics: Advances in Machine Learning Approaches and Sensor Architecture Design.. doi.org. https://doi.org/10.1021/acssensors.6c00796

See more details

More for · 6

Direct sampling of the peripheral lung identifies lung-derived volatile organic compounds detectable in exhaled breath: a feasibility study.

2026

Demonstrates that volatile organic compounds originating in the lung microenvironment are detectable in exhaled breath for lung cancer screening.

Get citation

R, M., KJ, K., DM, R., CL, B., SA, B., & S, L. (2026). Direct sampling of the peripheral lung identifies lung-derived volatile organic compounds detectable in exhaled breath: a feasibility study.. doi.org. https://doi.org/10.1088/1752-7163/ae8ffb

Metal-organic frameworks for breath-based sensors: a review.

2026

Discusses breath-based disease diagnosis by analyzing volatile organic compounds as unusual products of metabolism.

Get citation

I, G. & H, E. (2026). Metal-organic frameworks for breath-based sensors: a review.. doi.org. https://doi.org/10.1007/s00604-026-08290-2

A novel approach to non-invasive lung cancer screening via exhaled breath analysis using proton transfer reaction time-of-flight mass spectrometry.

2026

Identifies specific volatile organic compound ions in exhaled breath that differentiate lung cancer patients from controls.

Get citation

M, H. C., J, C., F, V., E, H., R, P., JA, H. E., RE, R., JR, S., AC, N., P, M., & O, A. (2026). A novel approach to non-invasive lung cancer screening via exhaled breath analysis using proton transfer reaction time-of-flight mass spectrometry.. doi.org. https://doi.org/10.1088/1752-7163/ae8ffc

Discriminating colorectal cancer via exhaled volatile organic compounds.

2026

Finds a panel of exhaled volatile organic compounds that successfully discriminates colorectal cancer from controls and other conditions.

Get citation

Y, J., W, W., S, D., Y, H., Z, Y., Y, Z., & X, L. (2026). Discriminating colorectal cancer via exhaled volatile organic compounds.. doi.org. https://doi.org/10.1093/qjmed/hcaf317

Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines.

2026

Demonstrates that colorectal cancer cell lines emit distinct volatile organic compound profiles reflecting cellular metabolism.

Get citation

C, H., A, L., A, M., C, A., A, K., CA, M., & P, M. (2026). Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines.. doi.org. https://doi.org/10.3390/ijms27146240

Electronic nose versus gas chromatography - mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis.

2026

Shows that volatile organic compound profiling via eNose and GC-MS successfully distinguishes hepatocellular carcinoma patients from controls.

Get citation

MS, M., MS, M., HN, A., MM, S., RA, M., & EI, M. (2026). Electronic nose versus gas chromatography - mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis.. doi.org. https://doi.org/10.1186/s12876-026-04795-5

Related receipts

Is it true that car air fresheners release volatile organic compounds that harm human health? PARTIAL LEAN related question, same topic

Receipt History

first checked05 Aug 2026

judged → SUPPORTED · 7805 Aug 2026

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work